Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-01

Study Completion Date

2020-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Extracorporeal shock wave lithotripsy (ESWL) is widely used in the treatment of urinary tract stones and is generally applied to outpatients. To achieve fragmentation in ESWL, shock waves must be applied with sufficient power and time. Providing effective analgesia during this procedure is crucial to the success of the procedure. Erector Spinae Plan Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in urinary system surgery. This study aimed to investigate the efficacy of ESPB in patients undergoing ESWL.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Analgesic Efficacy of Ultrasound Guided Quadratus Lumborum Block During ESWL

NCT03080363

Pain, Acute

COMPLETED PHASE4

Analgesic Effect of Erector Spinae Plane Block for Renal Colic Pain

NCT04209439

Renal Colic

COMPLETED PHASE4

Quadratus Lumborum Block Versus Erector Spinae Plane Block in Extracorporeal Shock Wave Lithotripsy(ESWL)

NCT05937256

Pain Lithiasis

COMPLETED NA

Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy

NCT03652103

Nephrolithotomy, Percutaneous Anesthetics, Local Nerve Block +3 more

COMPLETED PHASE4

Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy

NCT06078241

Postoperative Analgesia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary System Stones Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group ESPB

Ultrasound-guided erector spinae plane block with 10 ml %0.5 bupivacaine and 10 ml %2 lidocaine

Group Type ACTIVE_COMPARATOR

Bupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml

Intervention Type DRUG

Erector spinae plane block, 30 min before the ESWL procedure.

Group NSAII

lidocaine 5% gel and 800 mg ibuprofen intravenously

Group Type ACTIVE_COMPARATOR

5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously

Intervention Type DRUG

5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously, 30 min before the ESWL procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml

Erector spinae plane block, 30 min before the ESWL procedure.

Intervention Type DRUG

5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously

5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously, 30 min before the ESWL procedure.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologist's physiologic state I-II patients undergoing Extracorporeal Shockwave Lithotripsy

Exclusion Criteria

* chronic pain
* bleeding disorders
* renal or hepatic insufficiency
* patients on chronic non-steroidal anti-inflammatory medications
* emergency cases

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No